Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
966
NCT05243654
Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy
Phase: Phase 2
Role: Collaborator
Start: Oct 1, 2022
Completion: Sep 30, 2026
NCT06441981
Public Perception and Policy for SARS-CoV-2 Whole Genome Sequencing and Genomics for All
Phase: N/A
Start: Oct 1, 2023
Completion: Dec 30, 2024